Location History:
- Exclesior, MN (US) (2022)
- Excelsior, MN (US) (2021 - 2024)
Company Filing History:
Years Active: 2021-2024
Title: Innovations of Roger Steven Mazze
Introduction
Roger Steven Mazze is an accomplished inventor based in Excelsior, MN (US). He holds three patents that focus on advancements in health monitoring technologies. His work primarily revolves around systems that measure and analyze biological data, particularly related to glucose levels.
Latest Patents
One of his latest patents is a biomarker monitoring fitness system. This system includes processes for measuring, monitoring, processing, and visualizing biological data, such as blood glucose levels. It facilitates the monitoring of fitness data through continuous glucose monitoring (CGM) sensors. The system can predict carbohydrate intake needs or insulin delivery requirements during physical activity, providing active indications to users. Additionally, it manages both de-identified and identifiable user fitness data.
Another significant patent is related to glucose exposure diagnostics and therapeutics. This invention measures glucose exposure on an hourly basis, which can indicate various underlying health conditions. If a patient's glucose exposure exceeds a certain threshold over a 24-hour period, treatments can be administered to help lower overall glucose levels.
Career Highlights
Roger Steven Mazze is associated with Tt1 Products, Inc., where he contributes his expertise in health technology innovations. His work has significantly impacted the field of fitness and health monitoring.
Collaborations
He collaborates with notable professionals, including Harold Philpott Southerland, III, and Todd Furneaux. Their combined efforts enhance the development of innovative health solutions.
Conclusion
Roger Steven Mazze's contributions to health monitoring technology through his patents demonstrate his commitment to improving individual health management. His innovative systems are paving the way for better understanding and management of glucose levels in users.